Avalere Health
An Inovalon Company

Market Access and Reimbursement

Optimize Access and Adoption

Today, an expanded universe of stakeholders are defining and evaluating the value of medical interventions beyond the requirements for FDA approval. Payers and providers develop utilization management strategies, including clinical pathways, appropriate use criteria, and bundled payments, to deliver value to the marketplace. Manufacturers also address evolving definitions of value by integrating customer needs and working with guideline and measure developers to ensure health outcome goals are met. Avalere looks at this complex world of commercialization through a single, yet multi-dimensional lens. We draw from policy expertise, private and public payer perspectives, patient and provider requirements, as well as a multitude of other stakeholders to create one integrated market strategy. Specifically, Avalere uses The Payer Edge®, our proprietary network of payer decision makers to inform your coverage and access action plan. From launching new technologies to navigating access challenges for existing products, we help you secure reimbursement and access.

What's Your Challenge?

  • Public and private payer landscape analysis
  • Distributor and specialty pharmacy strategies
  • Reimbursement tools: coding, pricing, contracting
  • Patient support services
  • Field team design and deployment strategy​

Complementary Products


Meet a few of our experts ready to partner with you.

All Staff

Reginald Williams

Senior Vice President


Reginald Williams, Senior Vice President, leads teams that deliver research, analytic, and strategic support to clients, with a focus on the needs of life sciences manufacturers and patient groups. He advises clients on medical technology policy, regulatory and market access strategies for new products, and the evolution of public and private payers' use of evidence for formulating coverage and reimbursement decisions, with a focus on the Medicare program.

Prior to joining Avalere, Reggie was a member of the health policy team at the National Academy of Social Insurance (NASI).He also served as the Howard R. Swearer Public Service intern in the Rhode Island Department of Health's Office of Minority Health.

Reggie has an AB in Biomedical Ethics from Brown University. He also serves on the board of directors of Mental Health America, a nonprofit dedicated to helping people live mentally healthier lives. He is a Patient-Centered Outcomes Research grant reviewer and a member of NASI and Health Technology Assessment International.

Amy Palatiello



Amy Thornton Palatiello, Director, advises clients on reimbursement and product commercialization for medical devices, diagnostics and pharmaceuticals with a focus on the impact of regulatory and legislative changes related to Medicare payment policy.  In particular, Amy has extensive experience in Medicare coverage policy, end-stage renal disease payment issues, and durable medical equipment (DME) competitive bidding policy.

Prior to Avalere, Amy was a Healthcare Policy Analyst for the Washington Research Group where she informed institutional investors from the nation's largest mutual, hedge, and retirement funds about how Washington legislation and regulations would impact publicly traded healthcare companies.  Amy also worked for the Centers for Medicare & Medicaid Services as a health policy specialist focusing on Part D implementation and waste, fraud and abuse policy.

Amy has an MPH in Health Policy and Administration from the University of Minnesota and a BA from the University of Wisconsin.

Rujul Desai

Vice President


Rujul Desai, Vice President, advises clients on market access, reimbursement, strategic contracting and regulatory solutions.  He applies his unique combination of experience in specialty pharmacy, biopharma, PBM, legal and regulatory services.  Rujul has special expertise working with clients to design and implement technology-enabled solutions along the patient journey and across the care coordination continuum.

Prior to joining Avalere, Rujul has held a number of leadership roles in the specialty industry, including at CVS Caremark, UCB, and Theracom.  He was also the founder of a specialty hub services company supporting biopharma products.  Rujul has significant health law experience, including practicing at the law firm of K&L Gates.

Rujul holds a JD from University of Houston and a BA from Rutgers University.  He is a combat veteran of the Global War on Terror, U.S. Army, Medical Service Corps, Captain (Ret.).

Tim Epple

Senior Manager


Tim Epple, Senior Manager, provides due diligence and advisory services to private equity firms investing in the healthcare sector.

Prior to joining Avalere, Tim was a Consultant at the Advisory Board Company, where he supported hospital and health system clients through the analysis and modeling of healthcare and regulatory data. Prior to that, in his role at ADVI Health, he provided advisory due diligence and strategic consulting to healthcare companies as well as private equity firms. He has experience working with healthcare providers, life sciences, and technology focused companies. 

Tim has a BA in Economics and a BA in Political Science from the University of Texas at Austin, and completed coursework towards an MS from Northwestern University.

« Back to Mobile Site